Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.
Diagn Cytopathol. 2023 Nov;51(11):716-723. doi: 10.1002/dc.25212. Epub 2023 Aug 17.
Thoracic SMARCA4-deficient undifferentiated tumour (SMARCA4-UT) is an unusual and aggressive tumour. While there are approximately 100 cases of this tumour reported in the literature, there are very few detailed descriptions of its cytomorphologic characteristics, and only rare cases in which primary diagnosis was made on cytologic material. Herein we present a case with a detailed description of the appearance on three specimen types: transbronchial needle aspiration (TBNA) cytology, transbronchial needle biopsy (TBNB) and effusion cytology. Thoracic SMARCA4-UT is an important diagnosis to clinch in modern pathology because of its prognostic and therapeutic implications. We discuss an integrated approach to clinching the diagnosis with reference to clinical, radiographic, morphologic and immunohistochemical features. We also discuss possible differential diagnoses, and how they can be excluded. Cytologic and/or small biopsy diagnosis is valuable in these cases as these tumours are typically not amenable to surgical resection. With the correct diagnosis, the patient may instead be a candidate for immune checkpoint inhibitors or experimental therapy targeting SWI/SNF deficiency.
胸内 SMARCA4 缺陷未分化肿瘤(SMARCA4-UT)是一种不常见且具有侵袭性的肿瘤。尽管文献中大约有 100 例此类肿瘤的报道,但对其细胞形态学特征的详细描述非常少,并且仅在极少数情况下可以通过细胞学材料做出原发性诊断。在此,我们介绍了一个病例,详细描述了三种标本类型的表现:经支气管针吸活检(TBNA)细胞学、经支气管针吸活检(TBNB)和胸腔积液细胞学。由于胸内 SMARCA4-UT 具有预后和治疗意义,因此在现代病理学中明确诊断非常重要。我们参考临床、影像学、形态学和免疫组织化学特征,讨论了明确诊断的综合方法。我们还讨论了可能的鉴别诊断,以及如何排除这些诊断。在这些病例中,细胞学和/或小活检诊断具有价值,因为这些肿瘤通常不适宜进行手术切除。通过正确诊断,患者可能成为免疫检查点抑制剂或针对 SWI/SNF 缺陷的实验性治疗的候选者。